Man Group plc - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 128 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
Man Group plc ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$376,000
-73.8%
28,983
-73.8%
0.00%
-83.3%
Q1 2021$1,435,000
-66.9%
110,555
-64.7%
0.01%
-68.4%
Q4 2020$4,331,000
-8.5%
313,183
-2.5%
0.02%0.0%
Q3 2020$4,732,000
-7.7%
321,253
+1.9%
0.02%
-26.9%
Q2 2020$5,124,000
+322.4%
315,331
+277.2%
0.03%
+225.0%
Q1 2020$1,213,000
+748.3%
83,588
+299.9%
0.01%
+700.0%
Q4 2018$143,000
-62.7%
20,900
-63.8%
0.00%0.0%
Q3 2018$383,000
+16.4%
57,700
-1.4%
0.00%0.0%
Q2 2018$329,000
+93.5%
58,500
+78.4%
0.00%0.0%
Q1 2018$170,00032,8000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
HealthInvest Partners AB 230,000$993,6001.92%
AlphaCentric Advisors LLC 352,500$1,522,8001.50%
NEA Management Company, LLC 3,969,834$17,149,6830.96%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 573,530$2,477,6500.76%
ARMISTICE CAPITAL, LLC 5,000,000$21,600,0000.38%
IRONWOOD INVESTMENT MANAGEMENT LLC 93,658$404,6030.27%
Artal Group S.A. 1,000,000$4,3200.24%
Virtus ETF Advisers LLC 64,786$279,8760.15%
TANG CAPITAL MANAGEMENT LLC 200,000$864,0000.13%
HighMark Wealth Management LLC 37,499$161,9960.12%
View complete list of AURINIA PHARMACEUTICALS INC shareholders